Findings of this pilot study to inform development of a multicenter trial of FMT in pediatric ulcerative colitis


2 The PediFETCh trial is being conducted through McMaster Children’s Hospital’s Division of Pediatric Gastroenterology and Nutrition, in collaboration with Rebiotix Inc., a clinical stage biotechnology company. RBX2660 is the company’s lead drug …

Read more